$250B
$6.55 Million
0.5% of portfolio
110,655
Q2 2021
Reduced 3.78%
$38.9B
$6.56 Million
0.5% of portfolio
86,019
Q1 2021
Reduced 31.2%
$41.4B
$6.57 Million
0.5% of portfolio
85,500
Q3 2023
Reduced 3.39%
$44.7B
$6.43 Million
0.49% of portfolio
47,920
Q4 2024
Reduced 11.42%
$112B
$6.22 Million
0.48% of portfolio
73,900
Q4 2024
New
$56.6B
$6.3 Million
0.48% of portfolio
92,200
Q4 2024
Reduced 4.16%
$269B
$6.08 Million
0.47% of portfolio
86,500
Q4 2021
Reduced 15.61%
$18.3B
$6.19 Million
0.47% of portfolio
115,010
Q1 2020
Added 36.9%
$224B
$6.09 Million
0.47% of portfolio
21,000
Q1 2019
New
$146B
$6.05 Million
0.46% of portfolio
228,000
Q4 2024
Reduced 1.08%
$92.8B
$6.04 Million
0.46% of portfolio
79,750
Q2 2022
Added 19.03%
$123B
$5.91 Million
0.45% of portfolio
20,200
Q2 2020
Added 98.04%
$53.1B
$5.48 Million
0.42% of portfolio
18,545
Q2 2022
Added 3.34%
$22.7B
$4.88 Million
0.37% of portfolio
13,180
Q2 2020
Added 29.47%
$39.7B
$4.76 Million
0.36% of portfolio
32,500
Q4 2024
New
$157B
$4.54 Million
0.35% of portfolio
121,000
Q2 2020
Added 59.21%
$42.2B
$4.27 Million
0.33% of portfolio
46,100
Q4 2024
Reduced 4.16%
$113B
$4.1 Million
0.31% of portfolio
44,950
Q4 2024
Reduced 3.23%
$141B
$3.82 Million
0.29% of portfolio
10,600
Q2 2023
Reduced 4.5%
$20.9B
$3.84 Million
0.29% of portfolio
45,376
Q4 2024
Reduced 0.55%
$204B
$3.69 Million
0.28% of portfolio
7,095
Q4 2024
Added 2,305.08%
$37.6B
$3.39 Million
0.26% of portfolio
110,342
Q1 2024
Added 1.85%
$128B
$3.37 Million
0.26% of portfolio
59,492
Q4 2024
Reduced 14.16%
$16.3B
$3.44 Million
0.26% of portfolio
62,332
Q2 2019
Reduced 19.4%
$47.2B
$3.45 Million
0.26% of portfolio
26,300
Q1 2022
Added 8.23%
$28.9B
$3.27 Million
0.25% of portfolio
17,500
Q3 2021
Reduced 68.75%
$36.3B
$3.16 Million
0.24% of portfolio
23,500
Q1 2020
New
$93.7B
$3.04 Million
0.23% of portfolio
15,091
Q1 2019
New
$105B
$2.97 Million
0.23% of portfolio
148,200
Q2 2024
Added 76.43%
$56.5B
$2.86 Million
0.22% of portfolio
75,000
Q4 2024
New
$191B
$2.73 Million
0.21% of portfolio
120,000
Q2 2020
Added 100.0%
$62.1B
$2.35 Million
0.18% of portfolio
9,740
Q1 2019
New
$48.6B
$2.23 Million
0.17% of portfolio
16,500
Q2 2023
New
$16B
$2.15 Million
0.16% of portfolio
44,333
Q1 2020
Added 129.31%
$784B
$1.93 Million
0.15% of portfolio
2,500
Q3 2020
New
$43.6B
$1.77 Million
0.14% of portfolio
24,603
Q1 2020
New
$16B
$1.77 Million
0.14% of portfolio
23,600
Q4 2024
Reduced 24.12%
-
$1.77 Million
0.14% of portfolio
-
Q4 2024
Reduced 11.03%
$44.3B
$1.74 Million
0.13% of portfolio
30,521
Q2 2019
New
$9.74B
$1.64 Million
0.13% of portfolio
175,326
Q1 2022
Reduced 2.77%
$177B
$1.7 Million
0.13% of portfolio
9,055
Q1 2019
New
-
$1.58 Million
0.12% of portfolio
-
Q4 2024
Reduced 3.42%
$1.13B
$1.4 Million
0.11% of portfolio
385,000
Q4 2024
Reduced 18.6%
$221B
$1.29 Million
0.1% of portfolio
7,701
Q1 2024
Reduced 35.45%
$26.4B
$1.17 Million
0.09% of portfolio
29,155
Q2 2019
New
$94.7B
$998,000
0.08% of portfolio
4,363
Q3 2020
Reduced 36.43%
$47.9B
$952,000
0.07% of portfolio
29,647
Q1 2019
New
-
$860,000
0.07% of portfolio
-
Q3 2024
Added 35.74%
Ge Healthcare Technologies
-
$682,000
0.05% of portfolio
-
Q2 2024
Reduced 4.55%
$22.2B
$363,000
0.03% of portfolio
3,125
Q4 2024
New